send to a friend by email

JPH records net income of $2.76 million in 9M 2019

2019-11-06

According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first nine months of 2019, Net profit after tax of the period reached 2,757,245 USD Compared with Net profit after tax 4,196,241 USD for 2018, a net decrease in profit of 34.29%.Total assets of the company reached 67,122,816 USD compared with total assets of 63,203,684 USD at the end of year 2018, a net increase of 6.20%.Total liabilities of the company reached 15,098,950 USD compared with total liabilities of 11,683,624 USD at the end of year 2018, a net increase of 29.23%. Net ownership equity of the company reached 52,023,866 USD (Including Non-Controlling Interests of 2,569,141 USD) compared with total owner equity of 51,520,060 USD (Including Non-Controlling Interests of 2,977,441 USD) at the end of year 2018, a net increase of 0.98%.